When drugs may cause cancer: A knotty challenge for US FDA
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has long grappled with how best to address questions over whether a drug used to treat various non-oncological conditions causes or influences cancer development and how this cancer risk can be evaluated.